Abstract
Sudden cardiac arrest (SCA) is a common cause of death in emergency departments, although SCA treatment has been improved with the improvement of medical and health care, the improvement of cardiopulmonary resuscitation technology, and the use of drugs and other therapeutic measures. However, the survival and discharge rate is still not optimistic. Post-cardiac arrest syndrome (PCAS) is a complex combination of pathophysiological processes, consisting of post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction, systemic ischemia-reperfusion response, and persistent precipitating pathology. This part will focus on the latest progress of post-resuscitation myocardial dysfunction, mainly focusing on the mechanism of ischemia-reperfusion injury, to provide basis for clinical treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mattiazzi A, Argenziano M, Aguilar-Sanchez Y, Mazzocchi G, Escobar AL. Ca2+ Sparks and Ca2+ waves are the subcellular events underlying Ca2+ overload during ischemia and reperfusion in perfused intact hearts. J Mol Cell Cardiol. 2015;79:69–78.
Nascimento AM, Lima EM, Brasil GA, et al. Serca2a and Na(+)/Ca(2+) exchanger are involved in left ventricular function following cardiac remodelling of female rats treated with anabolic androgenic steroid. Toxicol Appl Pharmacol. 2016;301:22–30.
Rusciano MR, Sommariva E, Douin-Echinard V, Ciccarelli M, Poggio P, Maione AS. CaMKII activity in the inflammatory response of cardiac diseases. Int J Mol Sci. 2019;20(18):4374.
Tribulova N, Seki S, Radosinska J, et al. Myocardial Ca2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death. Can J Physiol Pharmacol. 2009;87(12):1120–9.
Liu T, Takimoto E, Dimaano VL, et al. Inhibiting mitochondrial Na+/Ca2+ exchange prevents sudden death in a Guinea pig model of heart failure. Circ Res. 2014;115(1):44–54.
Bondarenko A, Svichar N, Chesler M. Role of Na+-H+ and Na+-Ca2+ exchange in hypoxia-related acute astrocyte death. Glia. 2005;49(1):143–52.
Ayoub IM, Kolarova J, Yi Z, et al. Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation. 2003;107(13):1804–9.
Gazmuri RJ, Radhakrishnan J, Ayoub IM. Sodium-Hydrogen Exchanger Isoform-1 inhibition: a promising pharmacological intervention for resuscitation from cardiac arrest. Molecules. 2019;24(9):1765.
White C, Ambrose E, Muller A, et al. Impact of reperfusion calcium and pH on the resuscitation of hearts donated after circulatory death. Ann Thorac Surg. 2017;103(1):122–30.
Ford KL, Moorhouse EL, Bortolozzi M, Richards MA, Swietach P, Vaughan-Jones RD. Regional acidosis locally inhibits but remotely stimulates Ca2+ waves in ventricular myocytes. Cardiovasc Res. 2017;113(8):984–95.
Fang X, Huang Z, Zhu J, et al. Ultrastructural evidence of mitochondrial abnormalities in postresuscitation myocardial dysfunction. Resuscitation. 2012;83(3):386–94.
Xu W, Fu Y, Jiang L, et al. Cardiopulmonary resuscitation ameliorates myocardial mitochondrial dysfunction in a cardiac arrest rat model. Am J Emerg Med. 2020;38:65–72.
Donnino MW, Liu X, Andersen LW, et al. Characterization of mitochondrial injury after cardiac arrest (COMICA). Resuscitation. 2017;113:56–62.
Bernardi P, Di Lisa F, Fogolari F, Lippe G. From ATP to PTP and Back: a dual function for the mitochondrial ATP synthase. Circ Res. 2015;116(11):1850–62.
van Vuuren D, Lochner A. Ischaemic postconditioning: from bench to bedside. Cardiovasc J Afr. 2008;19(6):311–20.
Alam MR, Baetz D, Ovize M. Cyclophilin D and myocardial ischemia-reperfusion injury: a fresh perspective. J Mol Cell Cardiol. 2015;78:80–9.
Cour M, Gomez L, Mewton N, Ovize M, Argaud L. Postconditioning: from the bench to bedside. J Cardiovasc Pharmacol Ther. 2011;16(2):117–30.
Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M. Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol Sci. 2017;38(7):592–607.
Zorov DB, Filburn CR, Klotz LO, Zweier JL, Sollott SJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192(7):1001–14.
Patil KD, Halperin HR, Becker LB. Cardiac arrest. Circ Res. 2015;116(12):2041–9.
Wang K, Wen S, Jiao J, et al. IL-21 promotes myocardial ischaemia/reperfusion injury through the modulation of neutrophil infiltration. Br J Pharmacol. 2018;175(8):1329–43.
Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656–65.
Laubach VE, Sharma AK. Mechanisms of lung ischemia-reperfusion injury. Curr Opin Organ Transplant. 2016;21(3):246–52.
Li RJ, Ji WQ, Pang JJ, Wang JL, Chen YG, Zhang Y. Alpha-lipoic acid ameliorates oxidative stress by increasing aldehyde dehydrogenase-2 activity in patients with acute coronary syndrome. Tohoku J Exp Med. 2013;229(1):45–51.
Eisenhardt SU, Weiss JB, Smolka C, et al. MicroRNA-155 aggravates ischemia-reperfusion injury by modulation of inflammatory cell recruitment and the respiratory oxidative burst. Basic Res Cardiol. 2015;110(3):32.
Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial ROS-induced ROS release: an update and review. Biochim Biophys Acta. 2006;1757(5–6):509–17.
Nickel A, Kohlhaas M, Maack C. Mitochondrial reactive oxygen species production and elimination. J Mol Cell Cardiol. 2014;73:26–33.
Bagheri F, Khori V, Alizadeh AM, Khalighfard S, Khodayari S, Khodayari H. Reactive oxygen species-mediated cardiac-reperfusion injury: mechanisms and therapies. Life Sci. 2016;165:43–55.
Macmillan-Crow LA, Cruthirds DL. Invited review: manganese superoxide dismutase in disease. Free Radic Res. 2001;34(4):325–36.
GarcÃa-Dorado D. Myocardial reperfusion injury: a new view. Cardiovasc Res. 2004;61(3):363–4.
Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med. 2009;361(16):1570–83.
Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am J Cardiol. 2010;106(3):360–8.
Conus S, Simon HU. Cathepsins: key modulators of cell death and inflammatory responses. Biochem Pharmacol. 2008;76(11):1374–82.
Liu XM, Yang ZM, Liu XK. Fas/FasL induces myocardial cell apoptosis in myocardial ischemia-reperfusion rat model. Eur Rev Med Pharmacol Sci. 2017;21(12):2913–8.
Chekeni FB, Elliott MR, Sandilos JK, et al. Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature. 2010;467(7317):863–7.
Lu J, Shen Y, Liu LJ, Qian HY, Zhu CL. Combining epinephrine and Esmolol attenuates excessive autophagy and Mitophagy in rat Cardiomyocytes after cardiac arrest. J Cardiovasc Pharmacol. 2015;66(5):449–56.
Wei H, Yin M, Lu Y, et al. Mild hypothermia improves neurological outcome in mice after cardiopulmonary resuscitation through Silent Information Regulator 1-actviated autophagy. Cell Death Discov. 2019;5:129.
Xue D, Wang Q, Chen Z, et al. 3-Anhydro-6-hydroxy-ophiobolin A, a fungal sesterterpene from Bipolaris oryzae induced autophagy and promoted the degradation of α-synuclein in PC12 cells. Bioorg Med Chem Lett. 2015;25(7):1464–70.
Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol Rev. 2019;99(4):1765–817.
Liu LF, Qian ZH, Qin Q, et al. Effect of melatonin on oncosis of myocardial cells in the myocardial ischemia/reperfusion injury rat and the role of the mitochondrial permeability transition pore. Genet Mol Res. 2015;14(3):7481–9.
Fink SL, Cookson BT. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun. 2005;73(4):1907–16.
Mou Y, Wang J, Wu J, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34.
Zhong H, Song R, Pang Q, et al. Propofol inhibits parthanatos via ROS-ER-calcium-mitochondria signal pathway in vivo and vitro. Cell Death Dis. 2018;9(10):932.
Meyer AS, Ostrowski SR, Kjaergaard J, Johansson PI, Hassager C. Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac arrest syndrome patients: study protocol for a randomized controlled trial. Trials. 2016;17:378.
Asai M, Takeuchi K, Saotome M, et al. Extracellular acidosis suppresses endothelial function by inhibiting store-operated Ca2+ entry via non-selective cation channels. Cardiovasc Res. 2009;83(1):97–105.
Yang Q, He GW, Underwood MJ, Yu CM. Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection. Am J Transl Res. 2016;8(2):765–77.
Bro-Jeppesen J, Johansson PI, Kjaergaard J, et al. Level of systemic inflammation and endothelial injury is associated with cardiovascular dysfunction and vasopressor support in post-cardiac arrest patients. Resuscitation. 2017;121:179–86.
Jones WK, Brown M, Ren X, He S, McGuinness M. NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc Toxicol. 2003;3(3):229–54.
Reyes LA, Boslett J, Varadharaj S, et al. Depletion of NADP(H) due to CD38 activation triggers endothelial dysfunction in the postischemic heart. Proc Natl Acad Sci U S A. 2015;112(37):11648–53.
Troelsen TT, Granfeldt A, Secher N, Tonnesen EK, Simonsen U. Impaired NO-mediated vasodilatation in rat coronary arteries after asphyxial cardiac arrest. Acta Anaesthesiol Scand. 2015;59(5):654–67.
Fink K, Schwarz M, Feldbrugge L, et al. Severe endothelial injury and subsequent repair in patients after successful cardiopulmonary resuscitation. Crit Care. 2010;14(3):R104.
Morgan RW, Sutton RM, Karlsson M, et al. Pulmonary vasodilator therapy in shock-associated cardiac arrest. Am J Respir Crit Care Med. 2018;197(7):905–12.
Yu X, Ge L, Niu L, Lian X, Ma H, Pang L. The dual role of inducible nitric oxide synthase in myocardial ischemia/reperfusion injury: friend or foe? Oxid Med Cell Longev. 2018;2018:8364848.
Mendez-Carmona N, Wyss RK, Arnold M, et al. Differential effects of ischemia/reperfusion on endothelial function and contractility in donation after circulatory death. J Heart Lung Transplant. 2019;38(7):767–77.
Zhang H, Wu Q, Wan Z, Cao Y, Zeng Z. Preconditioning but not postconditioning treatment with resveratrol substantially ameliorates postresuscitation myocardial dysfunction through the PI3K/Akt signaling pathway. Mol Med Rep. 2019;20(2):1250–8.
Wang G, Zhang Q, Yuan W, Wu J, Li C. Sildenafil protects against myocardial ischemia-reperfusion injury following cardiac arrest in a porcine model: possible role of the renin-angiotensin system. Int J Mol Sci. 2015;16(11):27015–31.
Xue L, Yang F, Han Z, et al. ALDH2 mediates the dose-response protection of chronic ethanol against endothelial senescence through SIRT1/p53 pathway. Biochem Biophys Res Commun. 2018;504(4):777–83.
Schanze N, Bode C, Duerschmied D. Platelet contributions to myocardial ischemia/reperfusion injury. Front Immunol. 2019;10:1260.
Eltzschig HK, Eckle T. Ischemia and reperfusion—from mechanism to translation. Nat Med. 2011;17(11):1391–401.
Mezger M, Nording H, Sauter R, et al. Platelets and immune responses during thromboinflammation. Front Immunol. 2019;10:1731.
Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384–91.
Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190(3):255–66.
Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med. 2007;357(11):1121–35.
Hayashida K, Miyazaki Y, Yu B, et al. Depletion of vascular nitric oxide contributes to poor outcomes after cardiac arrest. Am J Respir Crit Care Med. 2019;199(10):1288–90.
Asmussen A, Fink K, Busch HJ, et al. Inflammasome and toll-like receptor signaling in human monocytes after successful cardiopulmonary resuscitation. Crit Care. 2016;20(1):170.
Arslan F, Houtgraaf JH, Keogh B, et al. Treatment with OPN-305, a humanized anti-Toll-Like receptor-2 antibody, reduces myocardial ischemia/reperfusion injury in pigs. Circ Cardiovasc Interv. 2012;5(2):279–87.
Bergt S, Guter A, Grub A, et al. Impact of toll-like receptor 2 deficiency on survival and neurological function after cardiac arrest: a murine model of cardiopulmonary resuscitation. PLoS One. 2013;8(9):e74944.
Chen C, Feng Y, Zou L, et al. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. J Am Heart Assoc. 2014;3(1):e000683.
Zhang XY, Chen C, Zhang YB, et al. Role of toll-like receptor 3 in lung ischemia-reperfusion injury. Shock. 2016;46(4):405–11.
Jiang X, Kong B, Shuai W, et al. Loss of MD1 exacerbates myocardial ischemia/reperfusion injury and susceptibility to ventricular arrhythmia. Eur J Pharmacol. 2019;844:79–86.
Podolec J, Trabka-Zawicki A, Badacz R, et al. Chemokine RANTES and IL-1beta in mild therapeutic hypothermia-treated patients after out-of-hospital sudden cardiac arrest. Postepy Kardiol Interwencyjnej. 2019;15(1):98–106.
Qi Z, An L, Liu B, et al. Patients with out-of-hospital cardiac arrest show decreased human leucocyte antigen-DR expression on monocytes and B and T lymphocytes after return of spontaneous circulation. Scand J Immunol. 2018;88(4):e12707.
El-Menyar AA. The resuscitation outcome: revisit the story of the stony heart. Chest. 2005;128(4):2835–46.
Tulaimat A, Patel A, Wisniewski M, Gueret R. The validity and reliability of the clinical assessment of increased work of breathing in acutely ill patients. J Crit Care. 2016;34:111–5.
Bro-Jeppesen J, Johansson PI, Hassager C, et al. Endothelial activation/injury and associations with severity of post-cardiac arrest syndrome and mortality after out-of-hospital cardiac arrest. Resuscitation. 2016;107:71–9.
Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, Adembri C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care. 2015;19:26.
Li XX, Zhao L, Chang Y, et al. Ezetimibe prevents myocardial remodeling in an obese rat model by inhibiting inflammation. Acta Biochim Pol. 2018;65(3):465–70.
Jou C, Shah R, Figueroa A, Patel JK. The role of inflammatory cytokines in cardiac arrest. J Intensive Care Med. 2020;35(3):219–24.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Pan, C., Yuan, Q., Xu, F. (2021). Progress in Cardiorespiratory Ischemia-Reperfusion Injury. In: Zhu, H. (eds) Sudden Death. Springer, Singapore. https://doi.org/10.1007/978-981-15-7002-5_6
Download citation
DOI: https://doi.org/10.1007/978-981-15-7002-5_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7001-8
Online ISBN: 978-981-15-7002-5
eBook Packages: MedicineMedicine (R0)